Parental Support Package Reduces Burnout in Physicians in Training
via HealthDayTUESDAY, May 19, 2026 -- A parental support package can significantly mitigate postpartum burnout among childbearing physicians in training, according to a study published online May 13 in the Journal of the American Medical Association.
Atziri Rubio-Chavez, M.D., from Massachusetts General Hospital in Boston, and colleagues assessed the efficacy of a parental support package targeting perinatal stressors among childbearing physicians in training from early pregnancy through 24 weeks postpartum. The analysis included 143 participants randomly assigned to the intervention or usual care.
The researchers found that during the study period, mean burnout scores increased from 2.96 to 3.03 in the parental support package group and from 3.13 to 3.79 in the usual support group (adjusted between-group difference in change, −0.58). Interpersonal disengagement drove these differences (adjusted between-group difference in change, −0.70). The groups were similar with respect to emotional exhaustion scores.
"This is the first evidence that pragmatic support for physician trainees after the birth of a child can help reduce burnout and have a strong return on investment," coauthor Erika Rangel, M.D., also from Mass General, said in a statement. "With physician burnout estimated to cost $7,600 per employed physician, a $2,300 intervention represents a significant financial benefit."
One author disclosed being coinventor of and having a patent for the Well-Being Index instruments and the Mayo Leadership Index.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-20 02:48
Read more
- Somatic Symptoms Tied to Depression With Ovarian Cancer
- Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy
- Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial
- Clinical Trial Finds No Difference in Fluid Treatment Options for Pediatric Sepsis
- Optimal Sleep May Reduce Dementia Risk in Patients With Focal Epilepsy
- Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions